This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

National Research Corporation Passes Successful Voluntary Audit For Managing Confidential Healthcare Surveys, Analytics, And Outreach Systems

LINCOLN, Neb., Sept. 12, 2013 (GLOBE NEWSWIRE) -- National Research Corporation is proud to announce its successful completion and passing of the Service Organization Control (SOC) 2sm examination. The exam and report are designed to meet the needs of existing or potential customers who need assurance about the effectiveness of controls at a service organization that are relevant to security, availability, processing integrity, confidentiality, and privacy. National Research completed this voluntary audit in June as part of its commitment to providing the highest quality of products and solutions for clients across the healthcare continuum. "We are pleased that our SOC 2sm report has shown that we have the appropriate controls in place to mitigate risks related across the board from security to confidentiality," said Rochelle Delley, Chief Security Officer at National Research. "We want to make sure our clients are completely confident with the security behind the information and resources we provide them, and this audit does exactly that. National Research accomplished the following criteria through the audit. The criteria have been developed by the American Institute of CPAs (AICPA). •    Security. The system is protected against unauthorized access (both physical and logical). •    Availability. The system is available for operation and use as committed or agreed. •    Processing integrity. System processing is complete, accurate, timely, and authorized. •    Confidentiality. Information designated as confidential is protected as committed or agreed. •    Privacy. Personal information is collected, used, retained, disclosed, and destroyed in conformity with the commitments in the entity's privacy notice and with criteria set forth in generally accepted privacy principles issued by the AICPA.   A SOC 2sm report is available only for National Research clients by request. Please contact info@nationalrearch.com for additional information. About National Research Corporation For more than 30 years, National Research Corporation (NASDAQ: NRCIA|NRCIB) has been at the forefront of patient-centered care. Today, the company's focus on empowering customer-centric healthcare across the continuum extends patient-centered care to incorporate families, communities, employees, senior housing residents, and other stakeholders. Recognized by Modern Healthcare as one of the largest patient satisfaction firms in the U.S., National Research is dedicated to representing the true voice of patients and other healthcare stakeholders. This integration of cross-continuum metrics and analytics uncovers insights for effective performance improvement, quality measurement, care transitions, and many other factors that impact population health management. National Research is headquartered in Lincoln, Nebraska. For more information, call 800-388-4264, write to info@nationalresearch.com, or visit www.nationalresearch.com .

CONTACT: Scott Smith
         Director of Marketing
         National Research Corporation
         800-388-4264
         scsmith@nationalresearch.com

National Research Corporation Logo

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,001.22 -38.27 -0.22%
S&P 500 1,988.40 -3.97 -0.20%
NASDAQ 4,538.5510 +6.4470 0.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs